Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y. · 2024
Read Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. by Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y. (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc11077829.txt.
Description
Lin and colleagues explain why brain tumours resist immune attack in this 2024 review. Glioblastoma is the most common malignant brain tumour in adults. Standard care pairs surgery, radiation, and a drug called temozolomide, yet outcomes stay poor. A key reason is the suppressive immune climate inside the tumour.
The review details three cell groups that enforce that climate. Myeloid-derived suppressor cells make up only 4 to 8 percent of immune cells in the tumour, yet play a central role, the authors note. They help the tumour evade immunity, grow vessels, invade, and spread. Tumour-linked macrophages and regulatory T cells add further suppression. The authors survey new immune and targeted strategies built on this map. They argue that breaking this suppression is the pivotal step for better therapy.
Catalog record
| CREATOR | Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y. |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 376 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |